Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$709M |
| 2 |
Amazon
AMZN
|
+$653M |
| 3 |
Tesla
TSLA
|
+$457M |
| 4 |
Exxon Mobil
XOM
|
+$450M |
| 5 |
Uber
UBER
|
+$382M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$520M |
| 2 |
Netflix
NFLX
|
+$476M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$377M |
| 5 |
Apple
AAPL
|
+$374M |
Sector Composition
| 1 | Technology | 19.76% |
| 2 | Healthcare | 17.68% |
| 3 | Consumer Discretionary | 13.1% |
| 4 | Industrials | 7.95% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Atlantic American Corp
AAME
$65.9M
| $82K | ﹤0.01% |
33,400
+300
| +0.9% | +$737 |
|
3352
Flora Growth
FLGC
$13.3M
| $82K | ﹤0.01% |
1,554
+531
| +52% | +$28K |
|
3353
PharmaCyte Biotech
PMCB
$7M
| $82K | ﹤0.01% |
38,100
+5,200
| +16% | +$11.2K |
|
|
WHLM
3354
DELISTED
Wilhelmina International, Inc
WHLM
| $82K | ﹤0.01% |
20,000
| – | – |
|
|
LUNA
3355
DELISTED
Luna Innovations Incorporated
LUNA
| $82K | ﹤0.01% |
12,377
-15,924
| -56% | -$106K |
|
3356
Modular Medical
MODD
$38.3M
| $81K | ﹤0.01% |
44,500
+30,000
| +207% | +$54.6K |
|
|
VIOT
3357
Viomi Technology
VIOT
$233M
| $81K | ﹤0.01% |
80,764
+700
| +0.9% | +$702 |
|
|
TFFP
3358
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| $81K | ﹤0.01% |
11,497
+5,277
| +85% | +$37.2K |
|
3359
Matinas BioPharma
MTNB
$9M
| $80K | ﹤0.01% |
7,433
+3,146
| +73% | +$33.9K |
|
3360
NanoViricides
NNVC
$23M
| $80K | ﹤0.01% |
78,500
+2,400
| +3% | +$2.45K |
|
|
DXYN
3361
DELISTED
Dixie Group Inc
DXYN
| $80K | ﹤0.01% |
107,533
+8,533
| +9% | +$6.35K |
|
3362
Milestone Scientific
MLSS
$46.7M
| $79K | ﹤0.01% |
114,397
+86,500
| +310% | +$59.7K |
|
3363
TRX Gold Corp
TRX
$129M
| $79K | ﹤0.01% |
207,259
-232,055
| -53% | -$88.5K |
|
|
DYNT
3364
DELISTED
Dynatronics Corp
DYNT
| $79K | ﹤0.01% |
135,418
+700
| +0.5% | +$408 |
|
|
AACG
3365
ATA Creativity
AACG
$68M
| $78K | ﹤0.01% |
67,444
-6,600
| -9% | -$7.63K |
|
3366
Fortress Biotech
FBIO
$111M
| $78K | ﹤0.01% |
25,867
+4,292
| +20% | +$12.9K |
|
3367
HeartCore Enterprises
HTCR
$23.8M
| $78K | ﹤0.01% |
121,500
+2,306
| +2% | +$1.48K |
|
3368
Owlet
OWLT
$118M
| $77K | ﹤0.01% |
14,598
-1,600
| -10% | -$8.44K |
|
|
EIGR
3369
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $77K | ﹤0.01% |
+11,474
| New | +$77K |
|
|
CMCM
3370
Cheetah Mobile
CMCM
$269M
| $76K | ﹤0.01% |
33,545
-600
| -2% | -$1.36K |
|
|
MSC
3371
Studio City International Holdings
MSC
$986M
| $76K | ﹤0.01% |
11,800
-2,200
| -16% | -$14.2K |
|
3372
Sonnet BioTherapeutics
SONN
$25.5M
| $76K | ﹤0.01% |
5,469
+3,088
| +130% | +$42.9K |
|
|
HLTH
3373
DELISTED
Cue Health Inc. Common Stock
HLTH
| $76K | ﹤0.01% |
466,600
+142,800
| +44% | +$23.3K |
|
|
ODV
3374
Osisko Development Corp
ODV
$747M
| $75K | ﹤0.01% |
+25,698
| New | +$75K |
|
|
MMAT
3375
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $75K | ﹤0.01% |
+11,405
| New | +$75K |
|